6
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Therapeutic Response of Chronic Active Hepatitis B (Cahb) to Anewimmunomodulator:AM3. Immunohematological Effects

, , , , , & show all
Pages 141-164 | Published online: 28 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Villarrubia Vg, Moreno Koch Mc, Calvo C, González S & Alvarez-Mon M. (1997) The Immunosenescent Phenotype in Mice and Humans Can Be Defined by Alterations in the Natural Immunity Reversal by Immunomodulation with Oral Am3. Immunopharmacology and Immunotoxicology 19:1, pages 53-74.
Read now

Articles from other publishers (5)

S Martín-Vilchez, F Molina-Jiménez, J L Alonso-Lebrero, P Sanz-Cameno, Y Rodríguez-Muñoz, I Benedicto, P Roda-Navarro, M Trapero, L Aragoneses-Fenoll, S González, J P Pivel, A L Corbí, M López-Cabrera, R Moreno-Otero & P L Majano. (2008) AM3, a natural glycoconjugate, induces the functional maturation of human dendritic cells. British Journal of Pharmacology 154:3, pages 698-708.
Crossref
F. Millán Rodríguez, F. Rousaud Barón & A. Rousaud Barón. (2003) Estudio piloto del tratamiento coadyuvante de la cistitis recidivante de la mujer mediante am3 (inmunoferon®). Actas Urológicas Españolas 27:3, pages 196-201.
Crossref
Rafael Pérez-García, Alfonso Pérez-García, Dierik Verbeelen, Erica D. Bernstein, Vicente G. Villarrubia & Melchor Álvarez-Mon. (2002) AM3 (Inmunoferón®) as an adjuvant to hepatitis B vaccination in hemodialysis patients. Kidney International 61:5, pages 1845-1852.
Crossref
ALFREDO PRIETOEDUARDO REYESERICA D. BERNSTEINBELÉN MARTINEZJORGE MONSERRATJOSE LUIZ IZQUIERDOLUIS CALLOLPILAR de LUCASRUDOLFO ALVAREZ-SALAJOSÉ LUIS ALVAREZ-SALAVICENTE G. VILLARRUBIAMELCHOR ALVAREZ-MON. (2001) Defective Natural Killer and Phagocytic Activities in Chronic Obstructive Pulmonary Disease Are Restored by Glycophosphopeptical (Inmunoferón). American Journal of Respiratory and Critical Care Medicine 163:7, pages 1578-1583.
Crossref
K. Noel Masihi. 1996. Immunopharmacology Reviews Volume 2. Immunopharmacology Reviews Volume 2 157 199 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.